Strasbourg, France – Polyplus-transfection SA, which specializes in the development of innovative solutions for the delivery of nucleic acids in research and therapeutics, announces the completion of a funding round in which it raised EUR 2.5 million. This new round brings in new shareholders in Polyplus-transfection, AIRFI (Alsace Inter Regio Fonds d’Investissement) and Sudinnova, which […]
PALO ALTO, Calif. – StemCells, Inc. (Nasdaq:STEM) announced today that it has entered into an agreement to sell ten million shares of its common stock to selected institutional investors at a price of $1.00 per share, which represents a 10% discount to the closing price per share of January 6. The offering is expected to […]
PLYMOUTH MEETING, Pa. – Hycult Biotech Inc., a wholly owned Subsidiary of Hycult Biotech B.V., a provider of innovative immunology and cell biology solutions, has named Mr. Dino DiCamillo as Executive Director, of its newly incorporated U.S. Subsidiary. “I am proud to play a role in the development and execution of Hycult’s local strategy” .Mr. […]
Horizon Discovery (Horizon) a leading provider of research tools to support the development of personalized medicines, and the University of Washington (UW) announced today that they have entered into a two-year research collaboration aimed at generating a process for gene editing in inducible human pluripotent stem cells. The research will exploit the high efficiency and […]
Gyros Introduces New Immunoassay Kits to Improve Biotherapeutic Development and Production Workflows
Two companies independently launch assay kits for Gyrolab workstations Uppsala, Sweden: Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, announced today that Cygnus Technologies Inc. and Radix Biosolutions have launched kits specifically designed for compatibility with the company’s immunoassay platform. The kits are intended to save time and labor […]
FAIRFIELD, Conn. – GE today announces the appointment of two new company officers. GE currently has 200 GE officers globally. GE officers lead large revenue generating businesses or are in critical functional roles, helping to drive growth. Below are details on GE’s two new officers: Robert Duffy, 45, has been appointed vice president of Global […]
ATCC (American Type Culture Collection) offers normal human primary corneal epithelial cells, a perfect alternative test method platform for toxicological assays, which can also be used in research related to gene regulation, tissue development, wound healing, cell-matrix interactions, and drug development. Manassas, VA – Growth performance is assured when cultured with optimized cell-specific medium, growth […]
LEXINGTON, Ky. -Transposagen Biopharmaceuticals, Inc. (Transposagen), a leader in genetic modification technology, announced today that it has entered into a non-exclusive license agreement with Cellular Dynamics International (CDI), the world’s largest producer of human induced pluripotent stem (iPS) cell lines and tissue cells for drug discovery and safety. The license agreement allows CDI to use […]
Darmstadt, Germany – Merck KGaA announced today that it has acquired 100% of the share capital of Beijing Skywing Technology Co., Ltd., a leading supplier of cell-culture media products, related technical services and bioreactors for the Chinese biopharmaceutical industry. The company is headquartered in the Changping district of Beijing and currently employs 80 people. The […]
Navi Mumbai, Maharashtra – Global Pharmaceutical and Chemical Company, Merck Limited, opened its new Application and Technology Centre at Nerul, Navi Mumbai. Spread over 1700 sq. ft., the state-of-the-art Centre will enable Merck to offer customized application and technology solutions to its customers in fields ranging from drug discovery to automobile and decorative paints. Mr. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
